These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10623767)

  • 21. The anti-idiotypic antibody 1F7 selectively inhibits cytotoxic T cells activated in HIV-1 infection.
    Grant M; Smaill F; Muller S; Kohler H; Rosenthal K
    Immunol Cell Biol; 2000 Feb; 78(1):20-7. PubMed ID: 10651925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of major histocompatibility complex class I/peptide/beta2M tetramers to quantitate CD8(+) cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys.
    Egan MA; Kuroda MJ; Voss G; Schmitz JE; Charini WA; Lord CI; Forman MA; Letvin NL
    J Virol; 1999 Jul; 73(7):5466-72. PubMed ID: 10364294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells.
    Norris PJ; Moffett HF; Yang OO; Kaufmann DE; Clark MJ; Addo MM; Rosenberg ES
    J Virol; 2004 Aug; 78(16):8844-51. PubMed ID: 15280492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells.
    Buseyne F; Février M; Garcia S; Gougeon ML; Rivière Y
    Virology; 1996 Nov; 225(1):248-53. PubMed ID: 8918556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
    Yang OO; Kalams SA; Rosenzweig M; Trocha A; Jones N; Koziel M; Walker BD; Johnson RP
    J Virol; 1996 Sep; 70(9):5799-806. PubMed ID: 8709196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4+ T cells and macrophages.
    Zheng N; Fujiwara M; Ueno T; Oka S; Takiguchi M
    J Virol; 2009 Aug; 83(15):7668-77. PubMed ID: 19457989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of cytokine production in human immunodeficiency virus type 1 (HIV-1)-specific human CD8+ T cells after stimulation with HIV-1-infected CD4+ T cells.
    Fujiwara M; Takata H; Oka S; Tomiyama H; Takiguchi M
    J Virol; 2005 Oct; 79(19):12536-43. PubMed ID: 16160181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells.
    Salerno-Gonçalves R; Lu W; Achour A; Andrieu JM
    Immunol Lett; 1998 Dec; 64(2-3):71-7. PubMed ID: 9870657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses utilizing B-lymphoblastoid cell lines transduced with the CD4 gene and infected with HIV-1.
    McElrath MJ; Rabin M; Hoffman M; Klucking S; Garcia JV; Greenberg PD
    J Virol; 1994 Aug; 68(8):5074-83. PubMed ID: 8035507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4+ human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual.
    Curiel TJ; Wong JT; Gorczyca PF; Schooley RT; Walker BD
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):61-8. PubMed ID: 7678973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons.
    Bernard NF; Pederson K; Chung F; Ouellet L; Wainberg MA; Tsoukas CM
    AIDS; 1998 Nov; 12(16):2125-39. PubMed ID: 9833853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.
    Tomiyama H; Akari H; Adachi A; Takiguchi M
    J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gp120-specific cytotoxic T-lymphocyte function.
    Gupta S; Boppana R; Mishra GC; Saha B; Mitra D
    Immunology; 2008 Aug; 124(4):553-61. PubMed ID: 18298551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of cytotoxic-T-lymphocyte memory induction without virus-specific CD4+ T-Cell help on control of a simian immunodeficiency virus challenge in rhesus macaques.
    Tsukamoto T; Takeda A; Yamamoto T; Yamamoto H; Kawada M; Matano T
    J Virol; 2009 Sep; 83(18):9339-46. PubMed ID: 19587045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysis of human immunodeficiency virus type 1 antigen-expressing cells by CD4 and CD8 T cells ex vivo.
    Heinkelein M; Euler-König I; Klinker H; Rückle-Lanz H; Jassoy C
    J Infect Dis; 1996 Jul; 174(1):209-13. PubMed ID: 8655997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide.
    Bouhdoud L; Villain P; Merzouki A; Arella M; Couture C
    J Virol; 2000 Mar; 74(5):2121-30. PubMed ID: 10666241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency.
    Rinaldo CR; Huang XL; Fan Z; Margolick JB; Borowski L; Hoji A; Kalinyak C; McMahon DK; Riddler SA; Hildebrand WH; Day RB; Mellors JW
    J Virol; 2000 May; 74(9):4127-38. PubMed ID: 10756025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immune response to HIV-1 Nef. II. Induction of HIV-1/HIV-2 Nef cross-reactive cytotoxic T lymphocytes in peripheral blood lymphocytes of non-infected healthy individuals.
    Lucchiari-Hartz M; Bauer M; Niedermann G; Maier B; Meyerhans A; Elchmann K
    Int Immunol; 1996 Apr; 8(4):577-84. PubMed ID: 8671645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.